Yuki Kasahara

  • Citations Per Year
Learn More
Recombinant human soluble thrombomodulin (rTM) has been established and introduced in the clinic as a standard treatment for disseminated intravascular coagulation (DIC). However, the efficacy and(More)
  • 1